How N4 Pharma is maximising retail engagement with InvestorHub.

Most public companies primarily focus on their top shareholders, typically representing a small percentage of their total registry but owning a significant portion of the stock. While this has traditionally been an efficient way to manage investor relations, it overlooks the growing influence of retail investors who make up the majority of a public company's shareholder base.

Biotech is a notoriously complex industry, often filled with intricate scientific details that can be difficult for the average investor to grasp. N4 Pharma distinguishes itself by 1) breaking down important news into more understandable language and 2) giving the opportunity for investors to submit questions before a presentation, ensuring retail investors fully comprehend the company's developments. This approach not only demystifies the biotech space but also makes N4 Pharma more appealing to a broader audience of investors.

Public companies need an efficient way to deliver top-tier experiences to these investors without incurring excessive costs or time commitments from the leadership team.